Last10K.com

Nexien Biopharma, Inc. (NXEN) SEC Filing 10-Q Quarterly Report for the period ending Friday, December 31, 2021

Nexien Biopharma, Inc.

CIK: 1625288 Ticker: NXEN
Cover - shares
6 Months Ended
Dec. 31, 2021
Feb. 04, 2022
Cover [Abstract]  
Document Type10-Q 
Amendment Flagfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Document Period End DateDec. 31, 2021 
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2022 
Current Fiscal Year End Date--06-30 
Entity File Number000-55320 
Entity Registrant NameNEXIENBIOPHARMA, INC. 
Entity Central Index Key0001625288 
Entity Tax Identification Number26-2049376 
Entity Incorporation, State or Country CodeDE 
Entity Address, Address Line One4340E Kentucky Ave. 
Entity Address, Address Line TwoSuite 206 
Entity Address, City or TownGlendale 
Entity Address, State or ProvinceCO 
Entity Address, Postal Zip Code80246 
City Area Code(303) 
Local Phone Number495-7583 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companytrue 
Elected Not To Use the Extended Transition Periodfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 60,022,196

View differences made from one quarter to another to evaluate Nexien Biopharma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nexien Biopharma, Inc..

Continue

Assess how Nexien Biopharma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nexien Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Nexien Biopharma, Inc. provided additional information to their SEC Filing as exhibits

Ticker: NXEN
CIK: 1625288
Form Type: 10-Q Quarterly Report
Accession Number: 0001493152-22-003407
Submitted to the SEC: Tue Feb 08 2022 6:07:46 AM EST
Accepted by the SEC: Tue Feb 08 2022
Period: Friday, December 31, 2021
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/nxen/0001493152-22-003407.htm